Neurological Surgery 脳神経外科49巻3号

2021年05月発行

特集 グリオーマ—現在の常識と近未来のスタンダード Ⅳグリオーマ治療法update

放射線療法

著者： 井垣浩¹

所属機関： ¹国立がん研究センター中央病院放射線治療科

ページ範囲：P.575 - P.587

Point
・多様な病理型のグリオーマに対する放射線療法は，膠芽腫に対するエビデンスを基に構築されている．
・線量分割法や標的体積の決定法に関するエビデンスは少ない．
・強度変調放射線治療（IMRT），粒子線治療，ホウ素中性子捕捉療法（BNCT）などの新たな放射線治療モダリティが用いられるようになりつつある．

参考文献

1）Ostrom QT, et al：CBTRUS Statistical Report：Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol 21（Suppl 5）：v1-v100, 2019

2）Salazar OM, et al：High dose radiation therapy in the treatment of malignant gliomas：final report. Int J Radiat Oncol Biol Phys 5：1733-1740, 1979

3）Walker MD, et al：An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5：1725-1731, 1979

F-fluoroethyltyrosine PET? - a recurrence pattern analysis. Radiother Oncol 145：49-55, 2020

5）Buglione M, et al：Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy：could a margin reduction be proposed? J Neurooncol 128：303-312, 2016

6）Brandes AA, et al：Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma：correlation with MGMT promoter methylation status. J Clin Oncol 27：1275-1279, 2009

7）Malmström A, et al；Nordic Clinical Brain Tumour Study Group（NCBTSG）：Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma：the Nordic randomised, phase 3 trial. Lancet Oncol 13：916-926, 2012

8）Roa W, et al：Abbreviated course of radiation therapy in older patients with glioblastoma multiforme：a prospective randomized clinical trial. J Clin Oncol 22：1583-1588, 2004

9）Roa W, et al：International Atomic Energy Agency Randomized Phase Ⅲ Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme. J Clin Oncol 33：4145-4150, 2015

10）Shapiro WR, et al：Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71：1-9, 1989

11）喜多みどり，他：悪性グリオーマに対する放射線治療—照射野因子に関するprospective randomized clinical study．癌の臨床 35：1289-1294, 1989

12）Ramsey RG, Brand WN：Radiotherapy of glioblastoma multiforme. J Neurosurg 39：197-202, 1973

13）Sharma RR, et al：Local control of high-grade gliomas with limited volume irradiation versus whole brain irradiation. Neurol India 51：512-517, 2003

14）Halperin EC, et al：Radiation therapy treatment planning in supratentorial glioblastoma multiforme：an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 17：1347-1350, 1989

15）Minniti G, et al：Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 97：377-381, 2010

16）Gilbert MR, et al：Dose-dense temozolomide for newly diagnosed glioblastoma：a randomized phase Ⅲ clinical trial. J Clin Oncol 31：4085-4091, 2013

17）Stupp R, et al；European Organisation for Research and Treatment of Cancer（EORTC）；Canadian Brain Tumor Consortium；CENTRIC study team：Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter（CENTRIC EORTC 26071-22072 study）：a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 15：1100-1108, 2014

18）Kumar N, et al：Impact of volume of irradiation on survival and quality of life in glioblastoma：a prospective, phase 2, randomized comparison of RTOG and MDACC protocols. Neurooncol Pract 7：86-93, 2020

19）van den Bent MJ, et al ；EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council：Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults：the EORTC 22845 randomised trial. Lancet 366（9490）：985-990, 2005

20）Yang K, et al：Biopsy versus subtotal versus gross total resection in patients with low-grade glioma：a systematic review and meta-analysis. World Neurosurg 120：e762-e775, 2018

21）Singer JM：Supratentorial low grade gliomas in adults. A retrospective analysis of 43 cases treated with surgery and radiotherapy. Eur J Surg Oncol 21：198-200, 1995

22）Hanzély Z, et al：Role of early radiotherapy in the treatment of supratentorial WHO Grade Ⅱ astrocytomas：long-term results of 97 patients. J Neurooncol 63：305-312, 2003

23）Karim AB, et al：A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma：European Organization for Research and Treatment of Cancer（EORTC）Study 22844. Int J Radiat Oncol Biol Phys 36：549-556, 1996

24）Shaw E, et al：Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma：initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20：2267-2276, 2002

25）Lawrie TA, et al：Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma. Cochrane Database Syst Rev 8：CD013047, 2019

26）Gui C, et al：A prospective cohort atudy of neural progenitor cell-sparing radiation therapy plus temozolomide for newly diagnosed patients with glioblastoma. Neurosurgery 87：E31-E40, 2020

27）Brown PD, et al；Radiation Therapy Oncology Group（RTOG）：Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy：a randomized, double-blind, placebo-controlled trial. Neuro Oncol 15：1429-1437, 2013

28）Tedesco MA, et al：Does the angiotensin Ⅱ receptor antagonist losartan improve cognitive function? Drugs Aging 19：723-732, 2002

29）Robbins ME, et al：The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys 73：499-505, 2009

30）Dye NB, et al：Strategies for preservation of memory function in patients with brain metastases. Chin Clin Oncol 4：24, 2015

31）日本放射線腫瘍学会，他（編）：強度変調放射線治療（IMRT）ガイドライン．2008　https://www.jastro.or.jp/customer/guideline/2016/10/imrt.pdf（2020年10月29日アクセス）

32）厚生労働省：令和元年社会医療診療行為別統計．2020　https:/www.e-stat.go.jp/stat-search/files?page=1＆toukei=00450048＆tstat=000001029602（2020年10月29日アクセス）

33）Hulshof MC, et al：Hypofractionation in glioblastoma multiforme. Radiother Oncol 54：143-148, 2000

34）Sultanem K, et al：The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme：preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys 58：247-252, 2004

35）Floyd NS, et al：Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 58：721-726, 2004

36）Panet-Raymond V, et al：Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme：a safety and efficacy analysis. Int J Radiat Oncol Biol Phys 73：473-478, 2009

37）Reddy K, et al：Phase Ⅱ trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 84：655-660, 2012

38）Yoon SM, et al：Hypofractionated intensity-modulated radiotherapy using simultaneous integrated boost technique with concurrent and adjuvant temozolomide for glioblastoma. Tumori 99：480-487, 2013

39）Iuchi T, et al：Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 88：793-800, 2014

40）Omuro A, et al：Phase Ⅱ study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clin Cancer Res 20：5023-5031, 2014

41）Ney DE, et al：Phase Ⅱ trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol 122：135-143, 2015

42）医用原子力技術研究振興財団：日本の粒子線治療施設の紹介．2019　https://www.antm.or.jp/05_treatment/04.html（2020年10月29日アクセス）

43）Particle Therapy Co-Operative Group：Particle therapy facilities in clinical operation. 2020　https://www.ptcog.ch/index.php/facilities-in-operation（2020年10月29日アクセス）

44）Mizumoto M, et al：Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy. Pract Radiat Oncol 5：e9-e16, 2015

45）Mizoe JE, et al；Organizing Committee of the Central Nervous System Tumor Working Group：Phase Ⅰ/Ⅱ clinical trial of carbon ion radiotherapy for malignant gliomas：combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 69：390-396, 2007

46）Fitzek MM, et al：Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme：results of a phase Ⅱ prospective trial. J Neurosurg 91：251-260, 1999

47）Mohan R, et al：Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients：phase Ⅱ randomized study of protons vs. photons. Neuro Oncol 23：284-294, 2021

48）Kong L, et al：Particle radiation therapy in the management of malignant glioma：early experience at the Shanghai Proton and Heavy Ion Center. Cancer 126：2802-2810, 2020

49）Fetcko K, et al：Survival and complications of stereotactic radiosurgery：a systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas. Medicine（Baltimore）96：e8293, 2017

50）Souhami L, et al：Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme：report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60：853-860, 2004

51）Yamamoto T, et al：Boron neutron capture therapy for newly diagnosed glioblastoma. Radiother Oncol 91：80-84, 2009

52）Kawabata S, et al：Boron neutron capture therapy for newly diagnosed glioblastoma. J Radiat Res 50：51-60, 2009

53）Shiba H, et al：Boron neutron capture therapy combined with early successive bevacizumab treatments for recurrent malignant gliomas - a pilot study. Neurol Med Chir（Tokyo）58：487-494, 2018

54）Carson KA, et al：Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase Ⅰ and Ⅱ clinical trials. J Clin Oncol 25：2601-2606, 2007